Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group - Nabholtz,J.M.; Buzdar,A.; Pollak,M. (J Clin Oncol, 2000)